This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: David L. Wesche and His Malaria-Treatment Patent.
Introduction
David L. Wesche is an inventor associated with Silver Spring, Maryland. His patent describes an approach to treating malaria using desbutylhalofantrine instead of halofantrine, with the aim of avoiding cardioarrhythmias.
Latest Patents
Wesche is credited with 1 patent: “Method of Treating Malaria with Desbutylhalofantrine.” The invention proposes administering desbutylhalofantrine to patients with malaria in place of halofantrine. For adult treatment, it describes a dosage of 500 mg every six hours for three doses on the first day, repeated on day seven, for a total dosage of 3,000 mg. It also describes prophylactic doses of 50 to 1,000 mg, administered daily or once per week.
Career Highlights
The patent highlights Wesche’s contribution to research into malaria treatment and the potential use of desbutylhalofantrine as an alternative to halofantrine. The supplied information does not identify an employer.
Collaborations
Raymond Woosley and Brian G. Schuster are listed as Wesche’s coworkers.
Conclusion
David L. Wesche’s patent focuses on using desbutylhalofantrine for malaria treatment and prophylaxis, with a stated goal of avoiding cardioarrhythmias.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile